Andrew J. Wilson

发表

Driving Continuous Program Improvement By Integration Of Assessment Into Strategic Planning

Hassan E. Alfadala, Andrew J. Wilson, 2005 .

The Distribution of Person Refering Terms in Natural Conversation

David Zeitlyn, Andrew J. Wilson, 1995 .

Protective role of the epithelium of the small intestine and colon.

Andrew J. Wilson, John M. Mariadason, Peter R. Gibson, 1996 .

Erratum: PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab. (Cancer Res (2008) 68 (1953-61))

Sanjay Goel, Andrew J. Wilson, John M. Mariadason, 2008 .

Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth.

Andrew J. Wilson, H. Moses, C. Hong, 2015, Cancer letters.

An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules

Joshua C. Gilbert, Joshua A. Bittker, Andrew J. Wilson, 2013, Cell.

PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab.

Sanjay Goel, Andrew J. Wilson, John M Mariadason, 2008, Cancer research.

Kaposi's sarcoma‐associated herpesvirus (KSHV)/human herpesvirus 8 (HHV8)—a new human tumour virus

Andrew J. Wilson, A. Wilson, L. Brooks, 1997, The Journal of pathology.

KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine.

Andrew J. Wilson, P. Tamayo, S. Schreiber, 2015, Cancer research.

CCNE1 and BRD4 co-amplification in high-grade serous ovarian cancer is associated with poor clinical outcomes

Andrew J. Wilson, K. Roby, D. Khabele, 2020, Gynecologic oncology.

Panobinostat sensitizes cyclin E high, homologous recombination-proficient ovarian cancer to olaparib.

Andrew J. Wilson, D. Khabele, M. Crispens, 2016, Gynecologic oncology.

Augmented Serum Amyloid A1/2 Mediated by TNF-induced NF-κB in Human Serous Ovarian Epithelial Tumors

Andrew J. Wilson, D. Son, D. Khabele, 2017, Immune network.

BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer.

Andrew J. Wilson, Andrew V Kossenkov, Hengrui Zhu, 2017, Cell reports.

Protective Role of the Epithelium of the Small Intestine and Colon

Andrew J. Wilson, J. Mariadason, P. R. Gibson, 1996, Inflammatory bowel diseases.

The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.

Andrew J. Wilson, D. Arango, J. Mariadason, 2009, Cancer research.

Hdac3 is essential for the maintenance of chromatin structure and genome stability.

Andrew J. Wilson, Christina E. Wells, Zhongming Zhao, 2010, Cancer cell.

FERONIA restricts Pseudomonas in the rhizosphere microbiome via regulation of reactive oxygen species

Andrew J. Wilson, Yang Liu, Cara H. Haney, 2021, Nature Plants.

TR3 modulates platinum resistance in ovarian cancer.

Andrew J. Wilson, Joseph T. Roland, Annie Y. Liu, 2013, Cancer research.

High-Fat Diet-Induced Obese Effects of Adipocyte-Specific CXCR2 Conditional Knockout in the Peritoneal Tumor Microenvironment of Ovarian Cancer

Andrew J. Wilson, M. Whalen, D. Son, 2021, Cancers.

Aprataxin Tumor Levels Predict Response of Colorectal Cancer Patients to Irinotecan-based Treatment

Andrew J. Wilson, D. Arango, J. Mariadason, 2010, Clinical Cancer Research.

Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer

Andrew J. Wilson, F. Yull, D. Khabele, 2015, Molecular Cancer.

Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer

Andrew J. Wilson, F. Yull, D. Khabele, 2015, Journal of Ovarian Research.

Intestinal epithelial-specific PTEN inactivation results in tumor formation.

Andrew J. Wilson, J. Mariadason, G. Corner, 2011, American journal of physiology. Gastrointestinal and liver physiology.

The DNA damage mark pH2AX differentiates the cytotoxic effects of small molecule HDAC inhibitors in ovarian cancer cells

Andrew J. Wilson, S. Haggarty, S. Schreiber, 2011, Cancer biology & therapy.

Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors.

Andrew J. Wilson, L. Aaltonen, D. Arango, 2005, Cancer research.

An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression.

Sanjay Goel, Kenneth Fordyce, Ziqiang Yuan, 2009, Cancer research.

Proteomic changes during intestinal cell maturation in vivo.

Andrew J. Wilson, J. Mariadason, G. Corner, 2008, Journal of proteomics.

Application of gene expression profiling to colon cell maturation, transformation and chemoprevention.

Andrew J. Wilson, D. Arango, Wancai Yang, 2003, The Journal of nutrition.

Short chain fatty acids and colon cancer.

Andrew J. Wilson, D. Arango, Wancai Yang, 2002, The Journal of nutrition.

Symposium : Diet , Growth Factors and Cancer Short Chain Fatty Acids and Colon Cancer 1 , 2

Andrew J. Wilson, D. Arango, Wancai Yang, 2002 .

Romidepsin (FK228) combined with cisplatin stimulates DNA damage-induced cell death in ovarian cancer.

Andrew J. Wilson, D. Khabele, Jeanette Saskowski, 2012, Gynecologic oncology.

The molecular site of action of K(ATP) channel inhibitors determines their ability to inhibit iNOS-mediated relaxation in rat aorta.

Andrew J. Wilson, Andrew J Wilson, L. Clapp, 2002, Cardiovascular research.

Chemokine Network and Overall Survival in TP53 Wild-Type and Mutant Ovarian Cancer

Andrew J. Wilson, M. Whalen, D. Son, 2018, Immune network.

HDAC4 promotes growth of colon cancer cells via repression of p21.

Andrew J. Wilson, D. Arango, J. Mariadason, 2008, Molecular biology of the cell.

Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer

Andrew J. Wilson, M. J. Uddin, L. Marnett, 2015, OncoTarget.

Histone Deacetylase 3 (HDAC3) and Other Class I HDACs Regulate Colon Cell Maturation and p21 Expression and Are Deregulated in Human Colon Cancer*

Andrew J. Wilson, D. Arango, J. Mariadason, 2006, Journal of Biological Chemistry.

The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21

Andrew J. Wilson, D. Son, D. Khabele, 2010, Cancer biology & therapy.

Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.

Andrew J. Wilson, D. Arango, J. Mariadason, 2003, Cancer research.

Gene expression profiling of intestinal epithelial cell maturation along the crypt-villus axis.

Andrew J. Wilson, D. Arango, Wancai Yang, 2005, Gastroenterology.

Obesity-Induced Peritoneal Dissemination of Ovarian Cancer and Dominant Recruitment of Macrophages in Ascites

Andrew J. Wilson, M. Whalen, D. Son, 2018, Immune network.

EPHB4 and survival of colorectal cancer patients.

Andrew J. Wilson, John M Mariadason, L. Aaltonen, 2006, Cancer research.

EPHB 4 and Survival of Colorectal Cancer Patients

Andrew J. Wilson, L. Aaltonen, D. Arango, 2006 .

Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis

Andrew J. Wilson, T. Blackwell, F. Yull, 2020, Biomarker research.

Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer.

Andrew J. Wilson, P. Konstantinopoulos, D. Khabele, 2014, Gynecologic oncology.

Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer.

Andrew J. Wilson, A. Godwin, K. Fuh, 2021, Gynecologic oncology.

Thailandepsins are new small molecule class I HDAC inhibitors with potent cytotoxic activity in ovarian cancer cells: a preclinical study of epigenetic ovarian cancer therapy

Andrew J. Wilson, Yi-Qiang Cheng, D. Khabele, 2012, Journal of Ovarian Research.

Loss of a plant receptor kinase recruits beneficial rhizosphere-associated Pseudomonas

Andrew J. Wilson, Yang Liu, Cara H. Haney, 2020, bioRxiv.

Title: KRAS genomic status predicts the sensitivity of ovarian cancer cells to decitabine Running Title: KRAS status predicts sensitivity to decitabine in ovarian cancer Authors: Stewart ML, Tamayo

Chang, Andrew J. Wilson, Ym, 2015 .

Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction.

Andrew J. Wilson, D. Arango, J. Mariadason, 2010, Cancer research.

Amino Acid Availability Determines Plant Immune Homeostasis in the Rhizosphere Microbiome

Andrew J. Wilson, Yang Liu, Cara H. Haney, 2021, bioRxiv.

Optimizing Mannose “Click” Conjugation to Polymeric Nanoparticles for Targeted siRNA Delivery to Human and Murine Macrophages

Andrew J. Wilson, C. Duvall, F. Yull, 2019, ACS omega.

Mechanisms of disease pathogenesis in long QT syndrome type 5.

Andrew J. Wilson, Andrew J Wilson, S. Harmer, 2010, American journal of physiology. Cell physiology.

Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer

Andrew J. Wilson, W. Rathmell, J. Rathmell, 2022, BMC cancer.

Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancer

Andrew J. Wilson, F. Yull, T. Giorgio, 2020, BMC cancer.

Mechanisms of disease pathogenesis in 4 long QT syndrome type 5 5 6 7 8

Andrew J. Wilson, Andrew J Wilson, S. Harmer, 2009 .

The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer.

Andrew J. Wilson, M. Stubbs, B. Ruggeri, 2018, Gynecologic oncology.

Abnormal KCNQ1 trafficking influences disease pathogenesis in hereditary long QT syndromes (LQT1).

Andrew J. Wilson, M. Bitner-Glindzicz, Andrew J Wilson, 2005, Cardiovascular research.

The intrinsic mitochondrial membrane potential (Deltapsim) is associated with steady-state mitochondrial activity and the extent to which colonic epithelial cells undergo butyrate-mediated growth arrest and apoptosis.

Andrew J. Wilson, L. Augenlicht, B. Heerdt, 2003, Cancer research.

Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer

Andrew J. Wilson, F. Yull, D. Khabele, 2015, Molecular Cancer.

Butyrate-mediated Growth Arrest and Apoptosis Extent to Which Colonic Epithelial Cells Undergo Associated with Steady-State Mitochondrial Activity and the ) Ism ψ ∆ The Intrinsic Mitochondrial Membrane Potential ( Updated

Andrew J. Wilson, L. Augenlicht, B. Heerdt, 2003 .

TR3/Nur77 in colon cancer cell apoptosis.

Andrew J. Wilson, D. Arango, J. Mariadason, 2003, Cancer Research.

TR 3 / Nur 77 in Colon Cancer Cell Apoptosis 1

Andrew J. Wilson, D. Arango, J. Mariadason, 2003 .

CXCR2 is a negative regulator of p21 in p53-dependent and independent manner via Akt-mediated Mdm2 in ovarian cancer

Andrew J. Wilson, M. Whalen, D. Son, 2018, Oncotarget.

Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention.

Andrew J. Wilson, D. Arango, L. Augenlicht, 2002, Cancer research.

Nuclear Factor-Kappa B Activity in the Host-Tumor Microenvironment of Ovarian Cancer

Andrew J. Wilson, Andrew J Wilson, 2012 .

Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors

Andrew J. Wilson, L. Marnett, D. Khabele, 2018, Journal of Ovarian Research.

Environment-gene interactions in intestinal cancer.

Andrew J. Wilson, Wancai Yang, J. Mariadason, 2002, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Discovery of Furanone-Based Radiopharmaceuticals for Diagnostic Targeting of COX-1 in Ovarian Cancer

Andrew J. Wilson, M. J. Uddin, L. Marnett, 2019, ACS omega.

Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells

Andrew J. Wilson, D. Arango, J. Mariadason, 2004, British Journal of Cancer.

Resistance to butyrate-induced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation.

Andrew J. Wilson, J. Mariadason, L. Augenlicht, 2001, Gastroenterology.

Colonic epithelial cell activation and the paradoxical effects of butyrate.

Andrew J. Wilson, J. Mariadason, P. Gibson, 1999, Carcinogenesis.

Tr3 Modulates Platinum Resistance in Ovarian Cancer Administrative, Technical or Material Support

Andrew J. Wilson, Joseph T. Roland, Annie Y. Liu, 2022 .

Molecular and Cellular Pathobiology TR 3 Modulates Platinum Resistance in Ovarian Cancer

Andrew J. Wilson, Joseph T. Roland, Annie Y. Liu, 2013 .

Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer

Andrew J. Wilson, F. Yull, D. Khabele, 2021, Neoplasia.

c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis

Andrew J. Wilson, D. Arango, Wancai Yang, 2003, British Journal of Cancer.

Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model

Andrew J. Wilson, F. Yull, D. Khabele, 2013, Journal of Ovarian Research.

TR3 modulates platinum resistance in ovarian cancer.

Andrew J. Wilson, Joseph T. Roland, Annie Y. Liu, 2013, Cancer research.

Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer

Andrew J. Wilson, M. J. Uddin, L. Marnett, 2015, Oncotarget.

Hdac3 is essential for the maintenance of chromatin structure and genome stability.

Andrew J. Wilson, Christina E. Wells, M. Washington, 2010, Cancer cell.

Abstract 5788: Area deprivation index and ovarian cancer survival: Preliminary findings for two validated measures

Andrew J. Wilson, J. Schildkraut, F. Yull, 2020 .

Interleukin-8 stimulates the migration of human colonic epithelial cells in vitro.

Andrew J. Wilson, P. Gibson, K. Byron, 1999, Clinical science.

Erratum: PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab. (Cancer Res (2008) 68 (1953-61))

Andrew J. Wilson, D. Arango, J. Mariadason, 2008 .